24/7 Patient Assistance: 760-405-8205

James Maher, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information
  • Education & Training


    University of Oklahoma College of Medicine

    Medical School


    Jewish Hospital of Cincinnati



    Ohio State University Hospital


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Good Samaritan Hospital

    Languages: English/Spanish

    (213) 977-2121

    1225 Wilshire Blvd

    Los Angeles, California 90017

    Read More
  • Publications & Memberships

    Dr. James Maher has contributed to 3 publications.

    Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.

    Puhalla, S., Mrozek, E., Young, D., Ottman, S., McVey, A., Kendra, K., Merriman, N.J., Knapp, M., Patel, T., Thompson, M.E., Maher, J.F., Moore, T.D., Shapiro, C.L.; J Clin Oncol. 2008 Apr 1.

    See more >>

    Taxanes and capecitabine in combination: rationale and clinical results.

    Maher, J.F., Villalona-Calero, M.A.; Clin Breast Cancer. 2002 Jan.

    See more >>

    Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.

    Butts, C. A., Bodkin, D., Middleman, E. L., Englund, C. W., Ellison, D., Alam, Y., Kreisman, H., Graze, P., Maher, J., Ross, H. J., Ellis, P. M., McNulty, W., Kaplan, ...; J Clin Oncol. 2007 Dec 20.

    See more >>